Radial Compression Devices Market: By Product Type (Band/Strap Based, Knob Based, Plate Based By Technology, Disposable, Reusable), By Application (Diagnostic, Surgical Intervention), By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers) and By Geography  

The radial compression devices market was valued at USD 398.4 million in 2022 and is poised to grow at a significant CAGR of 7.6% over 2023-2029. Dial artery access is a development in contemporary interventional cardiology for cardiovascular testing and intervention. The smaller size of the artery and an easier position for safe compression with a decreased risk of severe access site haemorrhage, which may have a detrimental effect on prognosis, are the key benefits of using the radial artery. Since it has shown that routinely using radial artery access can lower both access site haemorrhage and overall mortality, particularly when combined with the concurrent use of strong antithrombotic drugs. Radial access issues are uncommon due to the superficial position and simplicity of compression, making access site maintenance following intervention simpler than with femoral access.

Radial Compression Devices Market Key Developments:

In Aug 2019, PreludeSYNC EVO, a radial compression device, was introduced in the US by Merit Medical. Following catheterization procedures, this sterile, one-time-use device helps to achieve hemostasis at the artery percutaneous access site.